Patent · US Active

Selective HDAC6 inhibitors

US10626100B2 · kind B2 · utility

0Cited by
7References
20Claims
0Family size

Assignees

Inventors

Key dates

Filing dateDec 21, 2017
Grant dateApr 21, 2020
Priority date—
Expiry dateDec 21, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C259/10
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides a compound having the structure:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.